109 related articles for article (PubMed ID: 15760103)
1. Cetirizine from topical phosphatidylcholine-hydrogenated liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Elzainy AA; Gu X; Simons FE; Simons KJ
AAPS J; 2004 Aug; 6(3):e18. PubMed ID: 15760103
[TBL] [Abstract][Full Text] [Related]
2. Cetirizine from topical phosphatidylcholine liposomes: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Elzainy AA; Gu X; Simons FE; Simons KJ
Biopharm Drug Dispos; 2004 Nov; 25(8):359-66. PubMed ID: 15490489
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Elzainy AA; Gu X; Simons FE; Simons KJ
AAPS PharmSci; 2003 Nov; 5(4):E28. PubMed ID: 15198516
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
Urien S; Tillement JP; Ganem B; Kuch MD
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
[TBL] [Abstract][Full Text] [Related]
5. Semisolid formulations containing cetirizine: human skin permeation and topical antihistaminic evaluation in a rabbit model.
Ciurlizza C; Fernández F; Calpena AC; Lázaro R; Parra A; Clares B
Arch Dermatol Res; 2014 Oct; 306(8):711-7. PubMed ID: 24997631
[TBL] [Abstract][Full Text] [Related]
6. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
7. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
[TBL] [Abstract][Full Text] [Related]
8. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
Simons FE; Simons KJ
J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
10. Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies.
Goindi S; Dhatt B; Kaur A
J Microencapsul; 2014; 31(7):716-24. PubMed ID: 24963956
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyzine- and cetirizine-loaded liposomes: effect of duration of thin film hydration, freeze-thawing, and changing buffer pH on encapsulation and stability.
Elzainy AA; Gu X; Simons FE; Simons KJ
Drug Dev Ind Pharm; 2005 Mar; 31(3):281-91. PubMed ID: 15830724
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
13. [Circadian rhythms in the toxic effects of the histamine antagonist cetirizine in mice].
Dridi D; Ben Attia M; Reinberg A; Boughattas NA
Pathol Biol (Paris); 2005 May; 53(4):193-8. PubMed ID: 15850951
[TBL] [Abstract][Full Text] [Related]
14. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
[TBL] [Abstract][Full Text] [Related]
15. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
Leroy T; van Neste D
Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Simons FE;
Pediatr Allergy Immunol; 2005 Mar; 16(2):97-103. PubMed ID: 15787865
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
[TBL] [Abstract][Full Text] [Related]
18. Cetirizine in horses: pharmacokinetics and pharmacodynamics following repeated oral administration.
Olsén L; Bondesson U; Broström H; Tjälve H; Ingvast-Larsson C
Vet J; 2008 Aug; 177(2):242-9. PubMed ID: 17581764
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Takahashi H; Zhang Y; Morita E
Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers.
Shen S; He Y; Zeng S
Chirality; 2007 Jun; 19(6):485-90. PubMed ID: 17394131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
